Immunic (IMUX)
NASDAQ:IMUX
Holding IMUX?
Track your performance easily

Immunic (IMUX) Financial Statements

1,190 Followers

Immunic Financial Overview

Immunic's market cap is currently ―. The company's EPS TTM is $-1.509; its P/E ratio is -1.19; Immunic is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.38M$ -24.79M$ -23.38M$ -22.77M$ -24.00M
EBITDA$ -21.35M$ -24.76M$ -23.36M$ -22.73M$ -23.98M
Net Income Common Stockholders$ -21.38M$ -29.58M$ -21.57M$ -22.77M$ -24.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.70M$ 97.31M$ 46.67M$ 59.70M$ 77.30M
Total Assets$ 86.49M$ 104.16M$ 54.30M$ 66.98M$ 88.75M
Total Debt$ 241.00K$ 433.00K$ 639.00K$ 789.00K$ 1.21M
Net Debt$ -79.46M$ -96.88M$ -46.03M$ -58.91M$ -76.09M
Total Liabilities$ 22.92M$ 20.58M$ 25.37M$ 18.57M$ 19.45M
Stockholders Equity$ 63.53M$ 83.58M$ 28.93M$ 48.41M$ 69.23M
Cash Flow-
Free Cash Flow$ -17.21M$ -24.00M$ -23.99M$ -7.56M$ -20.00M
Operating Cash Flow$ -17.03M$ -23.97M$ -14.03M$ -17.31M$ -19.98M
Investing Cash Flow$ -180.00K$ -31.00K$ -165.00K$ -44.00K$ 4.34M
Financing Cash Flow-$ 74.46M$ 604.00K$ 282.00K$ 96.00K
Currency in USD

Immunic Earnings and Revenue History

Immunic Debt to Assets

Immunic Cash Flow

Immunic Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis